These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 25675382

  • 21. Successful treatment of type B insulin resistance with mixed connective tissue disease by pulse glucocorticoids and cyclophosphamide.
    Yang H, Zhao J, Li Y, Lv F, Zhang S, Li Y.
    J Diabetes Investig; 2017 Jul; 8(4):626-628. PubMed ID: 28084020
    [Abstract] [Full Text] [Related]

  • 22. Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia.
    Bourron O, Caron-Debarle M, Hie M, Amoura Z, Andreelli F, Halbron M, Fonfrede M, Leroux G, Vigouroux C, Hartemann A.
    Lancet; 2014 Oct 25; 384(9953):1548. PubMed ID: 25390580
    [No Abstract] [Full Text] [Related]

  • 23. Rituximab therapy for the type B syndrome of severe insulin resistance.
    Coll AP, Thomas S, Mufti GJ.
    N Engl J Med; 2004 Jan 15; 350(3):310-1. PubMed ID: 14724317
    [No Abstract] [Full Text] [Related]

  • 24. Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report.
    Yang GQ, Li YJ, Dou JT, Wang BA, Lu JM, Mu YM.
    BMC Endocr Disord; 2016 May 03; 16(1):20. PubMed ID: 27142369
    [Abstract] [Full Text] [Related]

  • 25. Successful remission of type B insulin resistance syndrome without rituximab in an elderly male.
    Concepción-Zavaleta MJ, Ildefonso-Najarro SP, Plasencia-Dueñas EA, Quispe-Flores MA, Armas-Flórez CD, Luna-Victorio LE.
    Endocrinol Diabetes Metab Case Rep; 2020 Oct 14; 2020():. PubMed ID: 33434167
    [Abstract] [Full Text] [Related]

  • 26. Rituximab therapy for autoimmune haematological diseases.
    Barcellini W, Zanella A.
    Eur J Intern Med; 2011 Jun 14; 22(3):220-9. PubMed ID: 21570637
    [Abstract] [Full Text] [Related]

  • 27. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
    Baerlecken NT, Schmidt RE.
    Clin Rheumatol; 2013 Mar 14; 32 Suppl 1():S19-20. PubMed ID: 20213127
    [Abstract] [Full Text] [Related]

  • 28. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.
    Sims RE, Rushford FE, Huston DP, Cunningham GR.
    South Med J; 1987 Jul 14; 80(7):903-6. PubMed ID: 3603112
    [Abstract] [Full Text] [Related]

  • 29. A patient with type B insulin resistance syndrome, responsive to immune therapy.
    Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE.
    Nat Clin Pract Endocrinol Metab; 2007 Dec 14; 3(12):835-40. PubMed ID: 18026162
    [Abstract] [Full Text] [Related]

  • 30. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.
    Grenda R, Jarmużek W, Piątosa B, Rubik J.
    Pediatr Transplant; 2011 Sep 14; 15(6):E121-5. PubMed ID: 20331516
    [Abstract] [Full Text] [Related]

  • 31. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.
    Feldman RJ, Christen WG, Ahmed AR.
    Br J Dermatol; 2012 Mar 14; 166(3):511-7. PubMed ID: 21967407
    [Abstract] [Full Text] [Related]

  • 32. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P.
    Medicine (Baltimore); 2002 Mar 14; 81(2):87-100. PubMed ID: 11889410
    [No Abstract] [Full Text] [Related]

  • 33. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
    Wendt M, Gunnarsson I, Bratt J, Bruchfeld A.
    Scand J Rheumatol; 2012 Mar 14; 41(2):116-9. PubMed ID: 22118245
    [Abstract] [Full Text] [Related]

  • 34. Type B insulin resistance complicated with systemic lupus erythematosus.
    Kawashiri SY, Kawakami A, Fujikawa K, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    Intern Med; 2010 Mar 14; 49(5):487-90. PubMed ID: 20190490
    [Abstract] [Full Text] [Related]

  • 35. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y, Foshee JB, Sontheimer RD.
    J Am Acad Dermatol; 2011 Apr 14; 64(4):773-8. PubMed ID: 20494477
    [Abstract] [Full Text] [Related]

  • 36. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.
    Heyes C, Nolan R, Leahy M, Gebauer K.
    Australas J Dermatol; 2012 Feb 14; 53(1):e1-4. PubMed ID: 22309343
    [Abstract] [Full Text] [Related]

  • 37. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J, Vela-Ojeda J, García-Manzano A, Majluf-Cruz A.
    Rev Invest Clin; 2011 Feb 14; 63(2):210-2. PubMed ID: 21717725
    [Abstract] [Full Text] [Related]

  • 38. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.
    Cancer Chemother Pharmacol; 2008 Sep 14; 62(4):741-3. PubMed ID: 18064461
    [Abstract] [Full Text] [Related]

  • 39. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX, Wu FQ, Wang F, Zhou ZX, Huang XL, Lu J.
    Zhonghua Er Ke Za Zhi; 2012 Sep 14; 50(9):697-704. PubMed ID: 23158822
    [Abstract] [Full Text] [Related]

  • 40. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)].
    Illner N, Wolf G.
    Dtsch Med Wochenschr; 2010 May 14; 135(3):71-4. PubMed ID: 20077379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.